Compare iShares Bitcoin Trust (IBIT) vs GeneDx Holdings Corp (WGS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
iShares Bitcoin Trust vs GeneDx Holdings Corp — how do they compare? iShares Bitcoin Trust trades at $36.23, while GeneDx Holdings Corp trades at $82.32 (market cap $2.44B). The key difference: GeneDx Holdings Corp is trading nearer its 52-week high, iShares Bitcoin Trust nearer its low. Which is the better fit depends on your goals.
| IBIT | WGS | |
|---|---|---|
Sector | Crypto-linked | Technology |
52-Week High | $71.29 | $167.51 |
52-Week Low | $33.29 | $34.51 |
Market Cap | — | $2.44B |
Enterprise Value | — | $2.48B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
IBIT trades at $36.24, showing minimal daily movement with a 0.01% gain. Technical indicators signal a bearish trend with moving averages in sell territory, though oscillators remain neutral. The stock faces resistance at $37 and finds support at $36. Recent news highlights institutional interest in crypto ETFs, with BlackRock's digital assets head noting 'overwhelming demand' (Bloomberg, August 10, 2026).
The outlook remains cautious due to bearish technical signals and Bitcoin's 50% decline from 2025 peaks. Long-term potential exists via institutional adoption, but near-term risks include crypto market volatility and selective ETF inflows. Investors should weigh technical weakness against BlackRock's growing ETF footprint.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About iShares Bitcoin Trust
IBIT is a spot Bitcoin ETF that tracks the price of Bitcoin directly. Managed by BlackRock, it offers investors a regulated way to gain exposure to the digital asset within a traditional brokerage account.
Read more on IBIT →About GeneDx Holdings Corp
GeneDx is a patient-centered health intelligence company that specializes in transforming healthcare through the application of genomics. It combines advanced technology with one of the world's largest rare disease genomic datasets to provide clinical-grade exome and genome sequencing, enabling precise and rapid diagnosis for patients with complex medical conditions.
Read more on WGS →
